Stay updated on PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.

Latest updates to the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page
- Check6 days agoChange DetectedThe page's revision metadata has been updated from v3.5.2 to v3.5.3, indicating a minor administrative update to the page's version history.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAn addition shows Revision: v3.5.2 and the prior Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the change log.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor version update with no impact on study details.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded Revision: v3.4.2. Removed outdated notices about government funding and operating status (for example, cc.nih.gov updates).SummaryDifference0.4%

- Check91 days agoChange DetectedThe page now shows a system notice about a lapse in government funding and that the NIH Clinical Center is open, with links to cc.nih.gov and opm.gov for status updates. The page also shows a revision from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.